About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Chicago | 90 Studies

Clinical Trials MigraineChicago

Migraine Clinical Trials in Chicago

Find 90 clinical trials for migraine near Chicago, Illinois. Connect with research centers in your area.

All Migraine trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 90 trials

Active not recruitingA Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine.NCT06047444·Birmingham, Alabama and 119 others

Migraine Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Assess an Auto-injector Being Used to Treat a Migraine AttackThe purpose of this research study is to evaluate an investigational auto-injector system for delivering sumatriptan under the skin for a single migraine attack.NCT00510419·San Francisco, California and 9 others

CompletedThe Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience MigrainesThe purpose of this study is to evaluate the safety and effect of nasal carbon dioxide in the treatment of mild headaches in people who have migraines.NCT00690716·Birmingham, Alabama and 14 others

CompletedAn Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsThe primary objective is to evaluate the safety of long-term treatment with NP101 as assessed by: * Subject self-examination skin irritation scores * Adverse events * Changes in…NCT00792103·Phoenix, Arizona and 33 others

RecruitingLong-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineThe purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).NCT04743141·Scottsdale, Arizona and 123 others

CompletedDose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of MigraineThe primary purpose of this study is to evaluate the efficacy of rimegepant (BMS-927711) compared with placebo in the acute treatment of migraine as measured by Pain Freedom…NCT01430442·Scottsdale, Arizona and 40 others

CompletedA Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine AttackIntraject is a needle-free, single use, disposable, subcutaneous delivery system pre-filled with 6mg Sumatriptan to be used by patients to treat acute migraine treatment.NCT00530517·Chicago, Illinois and 3 others

Active not recruitingA PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEMProspective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine.NCT06167655·Scottsdale, Arizona and 22 others

CompletedA Multicenter Assessment of ALD403 in Chronic MigraineThe purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.NCT02275117·Huntsville, Alabama and 91 others

CompletedA Study of Galcanezumab (LY2951742) in Adult Participants With Episodic MigraineThe purpose of this study is to assess whether galcanezumab is superior to rimegepant in the prevention of migraine in participants with episodic migraine.NCT05127486·Gilbert, Arizona and 76 others

RecruitingA Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.NCT07674654·Birmingham, Alabama and 112 others

CompletedExtension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic MigraineThe purpose of this study is to evaluate the safety and tolerability of atogepant 60 mg once a day for the prevention of migraine in participants with episodic migraine.NCT03939312·Chandler, Arizona and 112 others

CompletedAn Efficacy and Safety Study of Fremanezumab in Adults With MigraineThe purpose of this study is to evaluate the efficacy, safety, and tolerability of monthly and quarterly subcutaneous (sc) injections of fremanezumab compared with sc injections…NCT03308968·Huntsville, Alabama and 112 others

CompletedStudy Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine AttacksThe purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and…NCT00240617·Anniston, Alabama and 51 others

CompletedAn Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine ProphylaxisThe purpose of this extension study was to evaluate the safety and efficacy of donepezil hydrochloride after extended use in migraine prophylaxis.NCT01146509·Chicago, Illinois and 3 others

CompletedSafety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)This study consists of a 4-week screening period, a 24-week treatment period for all participants, followed by a 28-week treatment period extension (to 52 weeks in total) for a…NCT03557333·Birmingham, Alabama and 35 others

CompletedStudy to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine HeadacheThe primary objective of this study is to evaluate the efficacy and safety of dronabinol MDI for the acute treatment of moderate to severe migraine headache.NCT00123201·Huntsville, Alabama and 28 others

TerminatedA Study of K-645 in the Treatment of Multiple Migraine AttacksThis is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the…NCT07116499·Oceanside, California and 17 others

CompletedEfficacy and Safety Trial of BHV-2100 for the Acute Treatment of MigraineThis study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.NCT06603623·Gilbert, Arizona and 59 others

TerminatedA Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionThe purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT04804033·Phoenix, Arizona and 115 others

Page 1 of 5Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia